Catheter Precision, Inc.
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
VTAK$0.15-0.7%Stored close · as of Oct 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenues | $212 | $93 | $355 | $175 |
| Cost of revenues | 14 | 16 | 25 | 21 |
| Gross profit | 198 | 77 | 330 | 154 |
| Operating expenses | ||||
| Selling, general and administrative | 2,881 | 2,713 | 6,366 | 5,369 |
| Research and development | 155 | 81 | 258 | 118 |
| Acquired in-process research and development | 1,848 | — | 1,967 | — |
| Total operating expenses | 4,884 | 2,794 | 8,591 | 5,487 |
| Operating loss | (4,686) | (2,717) | (8,261) | (5,333) |
| Other expenses, net | ||||
| Interest income | 3 | 7 | 21 | 40 |
| Interest expense | (67) | (5) | (116) | (8) |
| Change in fair value of royalties payable due to related parties | (1,667) | (1,504) | (2,830) | (1,590) |
| Change in fair value of trading debt securities | 10 | — | 10 | — |
| Other expenses, net | (1) | (1) | (1) | (4) |
| Total other expenses, net | (1,722) | (1,503) | (2,916) | (1,562) |
| Loss from operations before income taxes | (6,408) | (4,220) | (11,177) | (6,895) |
| Income tax benefit | (950) | — | (1,674) | — |
| Net loss | (5,458) | (4,220) | (9,503) | (6,895) |
| Less: Net loss attributable to non-controlling interest | (349) | — | (349) | — |
| Net loss attributable to Catheter Precision, Inc. | $(5,109) | $(4,220) | $(9,154) | $(6,895) |
| Net loss per share attributable to Catheter Precision, Inc., basic and diluted | $(0.38) | $(5.57) | $(0.74) | $(9.19) |
| Weighted-average common shares used in computing net loss per share, basic and diluted | 13,336,088 | 757,340 | 12,341,614 | 750,130 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.